These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10792200)

  • 1. Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.
    Stacher G; Weber U; Stacher-Janotta G; Bauer P; Huber K; Holzäpfel A; Krause G; Steinborn C
    Br J Clin Pharmacol; 2000 May; 49(5):429-36. PubMed ID: 10792200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men.
    Stacher G; Gaupmann G; Schneider C; Stacher-Janotta G; Steiner-Mittelbach G; Abatzi TA; Steinringer H
    Br J Clin Pharmacol; 1989 Sep; 28(3):315-22. PubMed ID: 2789925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea.
    Chey WD; Cash BD
    Expert Opin Investig Drugs; 2005 Feb; 14(2):185-93. PubMed ID: 15757394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers.
    Clemens CH; Samsom M; Van Berge Henegouwen GP; Fabri M; Smout AJ
    Aliment Pharmacol Ther; 2002 May; 16(5):993-1002. PubMed ID: 11966509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracolonic glycerol induces abdominal contractions in rats: role of 5-HT3 receptors.
    Botella A; Fioramonti J; Eeckhout C; Bueno L
    Fundam Clin Pharmacol; 1998; 12(6):619-23. PubMed ID: 9818294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of 5-HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats.
    Morteau O; Julia V; Eeckhout C; Bueno L
    Fundam Clin Pharmacol; 1994; 8(6):553-62. PubMed ID: 7721233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.
    Painsipp E; Shahbazian A; Holzer P
    Br J Pharmacol; 2009 Nov; 158(5):1210-26. PubMed ID: 19785647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
    Hirata T; Keto Y; Funatsu T; Akuzawa S; Sasamata M
    J Pharmacol Sci; 2007 Jul; 104(3):263-73. PubMed ID: 17652911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.
    Acosta A; Camilleri M; Busciglio I; Boldingh A; Nelson AD; Burton D
    Dig Dis Sci; 2016 Mar; 61(3):852-60. PubMed ID: 26467700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers.
    Di Stefano M; Vos R; Klersy C; Lee KJ; Janssens J; Tack J
    Am J Gastroenterol; 2006 Dec; 101(12):2797-804. PubMed ID: 17227525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Eur J Pharmacol; 2008 Jun; 587(1-3):281-4. PubMed ID: 18456254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
    Houghton LA; Foster JM; Whorwell PJ
    Aliment Pharmacol Ther; 2000 Jun; 14(6):775-82. PubMed ID: 10848662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilansetron acts at its site of absorption to antagonize the sensitivity of mesenteric afferent fibres to 5-hydroxytryptamine in the rat jejunum.
    Hillsley K; Eeckhout C; Grundy D
    Neurosci Lett; 2000 Jan; 278(3):137-40. PubMed ID: 10653012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sexually dimorphic effect of cholera toxin: rapid changes in colonic motility mediated via a 5-HT3 receptor-dependent pathway in female C57Bl/6 mice.
    Balasuriya GK; Hill-Yardin EL; Gershon MD; Bornstein JC
    J Physiol; 2016 Aug; 594(15):4325-38. PubMed ID: 26990461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barostat examination of proximal site of the anastomosis in patients with rectal cancer after low anterior resection.
    Mochiki E; Nakabayashi T; Suzuki H; Haga N; Fujita K; Asao T; Kuwano H
    World J Surg; 2001 Nov; 25(11):1377-82. PubMed ID: 11760737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers.
    De Schryver AM; Andriesse GI; Samsom M; Smout AJ; Gooszen HG; Akkermans LM
    Aliment Pharmacol Ther; 2002 Mar; 16(3):603-12. PubMed ID: 11876716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility.
    Feinle C; Read NW
    Am J Physiol; 1996 Oct; 271(4 Pt 1):G591-7. PubMed ID: 8897877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M
    Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.